Enhanced sensitivity to apoptosis in Ras-transformed thyroid cells

被引:19
作者
Cheng, GJ [1 ]
Meinkoth, JL [1 ]
机构
[1] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA
关键词
Ras; Rap1A; thyroid; apoptosis;
D O I
10.1038/sj.onc.1204928
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ras. mutations, occur at high frequency in thyroid cancer. In vitro, the effects of Ras in thyroid cells are pleiotropic in that expression of activated Ras has been reported to, stimulate proliferation and apoptosis. An understanding of the factors that contribute to the survival versus demise of Ras-transformed cells is essential to our understanding, of the contribution of Ras to thyroid neoplasia and other cancers. Constitutive expression of oncogenic H-Ras sensitized Wistar rat thyroid (WRT) cells to apoptosis stimulated by multiple insults. When deprived of matrix attachment, Ras-transformed cells perished by apoptotic cell death at a high frequency. In contrast, parental cells were more resistant to suspension-induced cell death. Ras effects on anchorage-independent cell death were reproduced by a mutant protein that signals selectively to Raf-1, but not by mutant Ras that preferentially binds, to RalGDS. Expression of a Ras mutant that selectively activates PI3K resulted in substantial protection from detachment-induced cell death., MAPK activity was increased in, adherent Ras12V- and Rasl2V35S-expressing cells, but abolished upon detachment. Interestingly, impaired MAPK activity was sufficient to stimulate apoptosis in adherent Ras-transformed cells, but not in parental cells. Treatment with a PI3-K inhibitor also stimulated apoptosis, selectively in Ras-transformed cells. These results, demonstrate that constitutive expression of activated Ras elicits differential effects on the survival of thyroid cells., Moreover, Ras, expression results in a greater dependence of thyroid cells on MAPK and PI3K activity for their survival.
引用
收藏
页码:7334 / 7341
页数:8
相关论文
共 37 条
  • [1] Fas (APO-1, CD95)-mediated apoptosis in thyroid cells is regulated by a labile protein inhibitor
    Arscott, PL
    Knapp, J
    Rymaszewski, M
    Bartron, JL
    Bretz, JD
    Thompson, NW
    Baker, JR
    [J]. ENDOCRINOLOGY, 1997, 138 (11) : 5019 - 5027
  • [2] REVERSIBLE INHIBITION OF A THYROID-SPECIFIC TRANS-ACTING FACTOR BY RAS
    AVVEDIMENTO, VE
    MUSTI, AM
    UEFFING, M
    OBICI, S
    GALLO, A
    SANCHEZ, M
    DEBRASI, D
    GOTTESMAN, ME
    [J]. GENES & DEVELOPMENT, 1991, 5 (01) : 22 - 28
  • [3] DIFFERENTIAL EXPRESSION OF THYROGLOBULIN GENE IN NORMAL AND TRANSFORMED THYROID-CELLS
    AVVEDIMENTO, VE
    MONTICELLI, A
    TRAMONTANO, D
    POLISTINA, C
    NITSCH, L
    DILAURO, R
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1985, 149 (03): : 467 - 472
  • [4] THYROTROPIN RECEPTOR GENE-EXPRESSION IN ONCOGENE-TRANSFECTED RAT-THYROID CELLS - CORRELATION BETWEEN TRANSFORMATION, LOSS OF THYROTROPIN-DEPENDENT GROWTH, AND LOSS OF THYROTROPIN RECEPTOR GENE-EXPRESSION
    BERLINGIERI, MT
    AKAMIZU, T
    FUSCO, A
    GRIECO, M
    COLLETTA, G
    CIRAFICI, AM
    IKUYAMA, S
    KOHN, LD
    VECCHIO, G
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 173 (01) : 172 - 178
  • [5] EFFECT OF SERUM GROWTH-FACTORS AND PHORBOL ESTER ON GROWTH AND SURVIVAL OF HUMAN THYROID EPITHELIAL-CELLS EXPRESSING MUTANT RAS
    BOND, J
    DAWSON, T
    LEMOINE, N
    WYNFORDTHOMAS, D
    [J]. MOLECULAR CARCINOGENESIS, 1992, 5 (02) : 129 - 135
  • [6] BOND JA, 1994, ONCOGENE, V9, P281
  • [7] TRAIL death pathway expression and induction in thyroid follicular cells
    Bretz, JD
    Rymaszewski, M
    Arscott, PL
    Myc, A
    Ain, KB
    Thompson, NW
    Baker, JR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (33) : 23627 - 23632
  • [8] STEPWISE TRANSFORMATION OF PRIMARY THYROID EPITHELIAL-CELLS BY A MUTANT HA-RAS ONCOGENE - AN INVITRO MODEL OF TUMOR PROGRESSION
    BURNS, JS
    BLAYDES, JP
    WRIGHT, PA
    LEMOINE, L
    BOND, JA
    WILLIAMS, ED
    WYNFORDTHOMAS, D
    [J]. MOLECULAR CARCINOGENESIS, 1992, 6 (02) : 129 - 139
  • [9] Ras signaling through PI3K confers hormone-independent proliferation that is compatible with differentiation
    Cass, LA
    Meinkoth, JL
    [J]. ONCOGENE, 2000, 19 (07) : 924 - 932
  • [10] Cass LA, 1999, MOL CELL BIOL, V19, P5882